Canada’s Decision to Halt Funding for Creutzfeldt-Jakob Disease Autopsies Sparks Controversy and Concerns
In a move that has left many experts alarmed, the Canadian federal government has announced plans to discontinue funding for a critical program that performs autopsies on individuals suspected of having Creutzfeldt-Jakob disease (CJD), a rare and fatal neurodegenerative disorder. This decision, framed as a cost-saving measure, comes at a time when fiscal restraint is tightening across government departments. But here’s where it gets controversial: the cut could leave Canada vulnerable to undetected cases of chronic wasting disease (CWD), a prion disease spreading among deer, elk, and moose, primarily in Alberta and Saskatchewan. While CWD has never been confirmed in humans, its potential to jump species raises significant concerns—and this is the part most people miss.
The Public Health Agency of Canada (PHAC) confirmed the funding halt in an email sent to pathology labs nationwide on February 13, stating, ‘After careful consideration, we will be discontinuing financial support related to autopsy services for patients suspected of CJD.’ The program, which cost up to $1.3 million annually depending on the number of autopsies performed, completed 50 autopsies in 2023-24 and 44 in 2024-25. PHAC spokeswoman Anna Maddison defended the decision, citing advancements in live testing methods that reduce the need for postmortem confirmation. However, experts argue that these tests may not reliably detect CWD if it were to emerge in humans—a scenario they believe cannot be ruled out.
‘This is something that any scientist would say is a terrible idea,’ said Dr. Joel Watts, a biochemistry professor at the University of Toronto. ‘It’s one of these cases where I don’t think the government sees the big picture.’ Dr. Watts emphasizes that brain autopsies remain the gold standard for distinguishing CJD from other prion diseases, including potential CWD cases in humans. Without this tool, Canada risks missing early signs of a disease that could mimic CJD’s symptoms, such as memory loss and coordination issues.
CJD and CWD are both caused by misfolded proteins called prions, which are incurable and progressive. While CJD is rare in Canada—with only 445 cases reported since 2020—its most infamous variant, linked to mad cow disease, underscores the stakes of prion surveillance. The mad cow crisis of the late 1990s and early 2000s brought CJD into public consciousness, and experts fear history could repeat itself if CWD is not monitored rigorously.
‘In an era of funding cuts, when a disease is rare or not immediately seen as affecting humans, it’s easy to look away,’ warned Dr. Valerie Sim, a neurologist at the University of Alberta. ‘But my concern is for the potential of a repeat of history. We didn’t do a very good job protecting people from mad cow disease.’ Her words highlight a broader debate: should governments prioritize immediate cost savings over long-term public health preparedness?
Dr. Gerard Jansen, whose University of Ottawa lab conducted the federally funded autopsies, was blindsided by the decision. ‘Every patient after last Friday is out in the cold, and that includes biopsies,’ he said, noting that his lab often examines brain tissue to confirm or subtype CJD cases. The abrupt halt leaves a gap in Canada’s ability to monitor prion diseases, raising questions about the country’s readiness for emerging threats.
PHAC maintains that surveillance for human prion diseases, including potential novel forms like CWD, will continue through testing at the National Microbiology Laboratory in Winnipeg. However, the consensus among experts is clear: without autopsy capabilities, Canada’s ability to detect and respond to prion diseases is significantly compromised.
Is this a prudent financial decision or a dangerous gamble with public health? As Canada moves forward with this cut, the scientific community and the public alike must grapple with the implications. What do you think? Are we risking a repeat of past mistakes, or is this a necessary step in an era of fiscal restraint? Let us know in the comments below.
